疫苗接种对巴西住院新冠患者住院时长的影响
结果显示,在50-69岁人群中,未接种者从病房直接出院者的平均住院时长为12.51天,而加强针接种者为11.02天;未接种者从ICU到出院的平均间隔为19.29天,加强针接种者为16.92天。作者认为疫苗接种可缩短住院时长并减轻卫生系统负担。
要点
- 在50-69岁人群中,未接种者病房直接出院平均住院12.51天,加强针接种者为11.02天。
- 在50-69岁人群中,未接种者ICU到出院平均间隔19.29天,加强针接种者为16.92天。
- 疫苗接种者从医院到出院及从ICU到出院的出院概率均更高。
核心结论
- 疫苗接种减少了住院发生并缩短了从医院到出院及从ICU到出院的住院时长,有助于减轻卫生系统负担。
- 结果表明即使疫苗未能预防导致住院的严重病例,也能显著缩短住院时间。
研究设计与样本
- 采用竞争风险生存分析评估新冠院内病程,按病房、ICU、出院和死亡四种状态测量住院时长。
主要发现
- 超过半数住院患者未接种疫苗。
- 在50-69岁人群中,从病房直接出院者的平均住院时长在未接种者为12.51天(95%CI 12.39-12.63),在加强针接种者为11.02天(95%CI 10.98-11.07);20-49岁和70岁及以上年龄组观察到类似结果。
- 在所有年龄组中,未接种者从入院到进入ICU的平均时间更短。
- 在50-69岁年龄组中,从ICU到出院的平均间隔在未接种者为19.29天(95%CI 18.95-19.64),在加强针接种者为16.92天(95%CI 16.78-17.07),其他年龄组呈类似趋势。
- 在包括从医院到出院和从ICU到出院的路径中,接种疫苗者的出院概率更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The length of hospital stays for severe COVID-19 cases significantly impacts the overall burden on the health system. Current COVID-19 vaccines have proven effective at reducing severe cases. However, the influence of vaccination status on the progression of COVID-19 after hospitalization is not well understood. Here, we estimated the impact of vaccination on the length of stay of hospitalized COVID-19 cases in Brazil. METHODS: We utilized nationwide data from hospital stays due to COVID-19 and the vaccination status of over 1.6 million individuals who tested positive for COVID-19 between January 17, 2021, and January 31, 2022. A competing-risk survival analysis was conducted to assess the COVID-19 in-hospital progression. We considered the hospital pathway according to four states: ward, ICU, discharge and death and measuring the length of stay accordingly. FINDINGS: Over half of hospital patients were unvaccinated. For patients aged 50-69-year-olds, the average length of stay for those discharged directly from the hospital ward (ward-to-discharge) ranged from 12.51 days (95 % CI, 12.39-12.63) in the unvaccinated to 11.02 days (95 % CI, 10.98-11.07) in booster recipients. Similar results were observed in the 20-49 and 70 or + age groups. For all age groups, the average time between hospital admission and ICU entrance was shorter in the unvaccinated. In the 50-69 age group, the average interval between ICU and discharge was 19.29 days (95 % CI, 18.95-19.64) in the unvaccinated and 16.92 days (95 % CI, 16.78-17.07) in the booster recipients, with a similar trend in other age groups. A higher discharge probability was observed among vaccinated individuals including hospital-to-discharge and ICU-to-discharge pathways. INTERPRETATION: Vaccination reduced hospital admissions and length-of-stay across the hospital-to-discharge and ICU-to-discharge pathways, contributing to a reduced health system burden. Our results demonstrate that even when vaccines do not prevent severe cases leading to hospitalizations, they significantly shorten the duration of hospital stays. FUNDING: Fundação Oswaldo Cruz (FIOCRUZ), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Pan American Health Organization (PAHO), Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde do Ministério da Saúde do Brasil (DECIT/SCTIE/MS).
引用
- Dos Santos CVB, Coelho LE, de Noronha TG, et al. The impact of vaccination on the length of stay of hospitalized COVID-19 patients in Brazil. Vaccine. 2025. PMID: 39823850. doi:10.1016/j.vaccine.2025.126735
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。